🔎 Trials Near Me

Utama › Kardiomiopati › Michigan

Kajian klinikal Kardiomiopati di Michigan

7 kajian untuk Kardiomiopati sedang mencari peserta di lokasi di Michigan.

Bandar di Michigan

Teks kajian rasmi (Bahasa Inggeris)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Detroit
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07052903

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Henry Ford Health System, Detroit
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06563895

Danon Disease Natural History Study

  • University of Michigan, Ann Arbor
Mengambil pesertaKajian pemerhatian
Umur 8 ke atas · Semua jantina · Dikemas kini 28 Jul 2026 · NCT06214507

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

  • Henry Ford Health, Detroit
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT05034432

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • University of Michigan, Ann Arbor
Mengambil pesertaFasa 3
Umur 18 hingga 90 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06128629

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

  • Henry Ford Health System, Detroit
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2025 · NCT06964464

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

  • University of Michigan, Ann Arbor
  • Henry Ford Hospital, Detroit
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 65 · Semua jantina · Dikemas kini 16 Mei 2025 · NCT06976606

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.